Comparative Pharmacology
Head-to-head clinical analysis: ALPHAREDISOL versus RUBIVITE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ALPHAREDISOL versus RUBIVITE.
ALPHAREDISOL vs RUBIVITE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cyanocobalamin (vitamin B12) acts as a cofactor for methionine synthase and L-methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis. Alpharedisol is a cyanocobalamin formulation that corrects vitamin B12 deficiency.
Hydroxocobalamin is a synthetic form of vitamin B12 that acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase, essential for DNA synthesis, erythrocyte maturation, and neurological function. In cyanide poisoning, it binds cyanide ions to form nontoxic cyanocobalamin, which is excreted renally.
Hydroxocobalamin 1 mg intramuscularly once daily for 5-10 days, then 1 mg once monthly for life.
1000 mcg intramuscularly or deep subcutaneous injection once daily for 5-7 days, then 100-1000 mcg monthly for maintenance.
None Documented
None Documented
1.5 hours in healthy adults; prolonged to 3-6 hours in renal impairment
Terminal elimination half-life is approximately 6-8 hours in patients with normal renal function; prolonged in renal impairment (up to 24-48 hours in severe impairment)
Renal (90% as unchanged drug); biliary/fecal (10%)
Primarily renal; ~50-80% of absorbed dose excreted unchanged in urine within 24 hours; biliary/fecal excretion accounts for minor fraction (<10%)
Category C
Category C
Vitamin B12 Supplement
Vitamin B12 Supplement